TABLE 4.

Respondents’ Self-Reported Use of Diabetes Therapies

Diabetes TherapiesRespondents With Type 1 Diabetes (%)Respondents With Type 2 Diabetes (%)
Insulin10048
Noninsulin injections (e.g., Bydureon [exenatide extended release], Byetta [exenatide], Victoza [liraglutide], or Symlin [pramlintide])213
Pills473
Diet and exercise<18